What are broad spectrum antibiotics produced from?

Broad spectrum antibiotics are produced from Streptomyces. These bacteria are renowned for their ability to synthesize a wide array of antibiotics with broad activity against diverse bacterial species. Streptomyces antibiotics include well-known drugs such as streptomycin, tetracycline, and erythromycin, which are used to treat various bacterial infections in clinical practice. The complex secondary metabolites produced by Streptomyces exhibit diverse chemical structures and mechanisms of action, targeting essential bacterial processes such as protein synthesis, cell wall synthesis, and nucleic acid synthesis. Due to their broad spectrum of activity, Streptomyces antibiotics are valuable therapeutic agents for treating infections caused by both Gram-positive and Gram-negative bacteria. Additionally, they play a crucial role in agriculture and biotechnology, contributing to the control of plant pathogens and the production of recombinant proteins. Overall, Streptomyces antibiotics are indispensable tools in modern medicine and biotechnology, offering effective treatment options for a wide range of bacterial diseases.